Longreen Corporation 4 in1 Reishi Coffee, 18.2 grams/sachet, 10 sachets/box
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1206-2024.
Undeclared allergens due to sub-ingredients, soy lecithin and coconut oil
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1206-2024.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Bf Suma Pharmaceuticals, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1206-2024.
BF Suma Pharmaceuticals, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Bf Suma Pharmaceuticals, Inc. Recall FAQ
Bf Suma Pharmaceuticals, Inc. is the subject of a beverages safety report: Longreen Corporation 4 in1 Reishi Coffee, 18.2 grams/sachet, 10 sachets/box. The notice was published on April 18, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 59,873 units are potentially affected.